MEDIUM confidence: 100% data completeness, but the composite (54) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $3.8B— | $3.3B-13.5% | $2.8B-16.9% | $2.8B+0.2% | $2.9B+3.7% |
| EPS (dil.) | $8.08— | $4.50-44.3% | $-0.95-121.1% | $2.41n/m | $2.08-13.7% |
| Free Cash Flow | $1.3B— | $594M-55.1% | $10M-98.3% | $542M+5369.0% | $508M-6.2% |
| Gross Margin | 59.6% | 53.2%-6.5pp | 48.1%-5.1pp | 48.0%-0.1pp | 53.1%+5.1pp |
| Operating Margin | 35.0% | 23.6%-11.4pp | 14.5%-9.1pp | 14.9%+0.4pp | 12.5%-2.4pp |
| Net Margin | 24.6% | 17.2%-7.5pp | -4.3%-21.5pp | 10.7%+15.0pp | 8.5%-2.3pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 5.8%/yr (revenue basis).
Base free cash flow $353M (avg FY2023–FY2025; latest year $508M) · equity value $17.5B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$1.3M over 180 days (0 open-market buys, 4 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $150 avg across 4 analysts.
Buy-rated share 35% → 33% over ~3 months (-2pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $1.21 | $1.41 | +16.5% |
| May 2026 | $1.02 | $1.06 | +3.9% |
| Feb 2026 | $1.57 | $1.70 | +8.3% |
| Oct 2025 | $1.14 | $1.18 | +3.5% |
| Jul 2025 | $1.14 | $1.18 | +3.5% |
| Apr 2025 | $0.96 | $1.01 | +5.2% |
| Jan 2025 | $1.37 | $1.42 | +3.6% |
| Nov 2024 | $1.13 | $1.28 | +13.3% |
The QScore of 54 for Revvity, Inc. suggests a neutral outlook, with the short-term score slightly outpacing the long-term score. Revvity scores high on momentum, driven by a 64.7% return over the past year, but is held back by low growth and value scores, due in part to a high P/E of 74.8. The company's profitability metrics, such as a 3.3% ROE, are also relatively modest. Overall, Revvity trades at a premium and exhibits strong momentum, but its growth prospects and valuation are less compelling.